Samsung Bioepis Co., Ltd. FDA Record
Samsung Bioepis Co., Ltd. has 1 FDA recall, 5 inspections, 0 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "Samsung Bioepis Co., Ltd." is on file. FDA has published 2 Form 483s for Samsung Bioepis Co., Ltd..
- Latest recall
- D-0099-2026 · Class II · Oct 10, 2025
- Latest inspection
- Nov 22, 2024 · VAI
Summary
| Records | Count | Last refreshed | Source as of | Status |
|---|---|---|---|---|
| Recalls | 1 | Nov 8, 2026 | File dated Nov 3, 2026 | Current |
| 510(k) clearances | 0 | Nov 8, 2026 | File dated Nov 2, 2026 | Current |
| Inspections | 5 | Nov 14, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions | 0 | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
FDA record by year
| Year | Inspections | OAI | Warning letters | Recall records | Class I |
|---|---|---|---|---|---|
| 2026 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 0 | 1 | 0 |
| 2024 | 1 | 0 | 0 | 0 | 0 |
| 2023 | 1 | 0 | 0 | 0 | 0 |
| 2022 | 0 | 0 | 0 | 0 | 0 |
| 2021 | 0 | 0 | 0 | 0 | 0 |
| 2020 | 0 | 0 | 0 | 0 | 0 |
| 2019 | 1 | 0 | 0 | 0 | 0 |
| 2018 | 1 | 0 | 0 | 0 | 0 |
| 2017 | 0 | 0 | 0 | 0 | 0 |
Reviewing Samsung Bioepis Co., Ltd. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Samsung Bioepis Co., Ltd. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Samsung Bioepis Co., Ltd. Form 483s
| Date | Document | FEI |
|---|---|---|
| Nov 22, 2024 | 483 | 3010031951 |
| Sep 15, 2023 | 483 | 3010031951 |
Recent recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0099-2026 | Class II | HADLIMA (adalimumab-bwwd) injection, 40mg/0.8 mL, 2 Single-dose Prefilled Syringes per carton, Rx… | Oct 10, 2025 |
Recent FDA inspections
| Date | Site | Product | Classification | FEI |
|---|---|---|---|---|
| Nov 22, 2024 | Yeonsu, Korea (The Republic Of) | Drugs | Voluntary Action Indicated (VAI) | 3010031951 |
| Sep 15, 2023 | Yeonsu, Korea (The Republic Of) | Drugs | Voluntary Action Indicated (VAI) | 3010031951 |
| Feb 15, 2019 | Yeonsu, Korea (The Republic Of) | Drugs | No Action Indicated (NAI) | 3010031951 |
| Apr 6, 2018 | Suwon, Korea (The Republic Of) | Drugs | No Action Indicated (NAI) | 3014114724 |
| Aug 19, 2016 | Yeonsu, Korea (The Republic Of) | Drugs | Voluntary Action Indicated (VAI) | 3010031951 |
- NAI
- No objectionable conditions or practices were found during the inspection.
- VAI
- Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
- OAI
- Regulatory and/or administrative actions are recommended.
FDA-inspected facilities
| Facility | Location | Inspections | Latest |
|---|---|---|---|
| FEI 3010031951 | Yeonsu, Korea (The Republic Of) | 4 | Nov 22, 2024 |
| FEI 3014114724 | Suwon, Korea (The Republic Of) | 1 | Apr 6, 2018 |
Samsung Bioepis Co., Ltd. and the FDA: common questions
Has Samsung Bioepis Co., Ltd. received an FDA warning letter?
No FDA warning letter addressed to the name "Samsung Bioepis Co., Ltd." is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.
Has Samsung Bioepis Co., Ltd. received an FDA Form 483?
FDA has published 2 Form 483s for Samsung Bioepis Co., Ltd. in its reading room, the most recent dated Nov 22, 2024. FDA publishes some Form 483s, not all of them.
When did the FDA last inspect Samsung Bioepis Co., Ltd.?
The most recent FDA inspection on file ended Nov 22, 2024 at Yeonsu, Korea (The Republic Of) and was classified VAI. FDA has 5 inspections of Samsung Bioepis Co., Ltd. on file.
Has Samsung Bioepis Co., Ltd. had an FDA recall?
Yes. Samsung Bioepis Co., Ltd. has 1 FDA recall on record. The most recent started Oct 10, 2025.
Need more than this page shows? Ask about Samsung Bioepis Co., Ltd. in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.